Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Sports Medicine
Published in: Sports Medicine 5/2009

01-05-2009 | Review Article

Exercise and Fatigue

Authors: Wim Ament, Gijsbertus J. Verkerke

Published in: Sports Medicine | Issue 5/2009

Login to get access

Abstract

Physical exercise affects the equilibrium of the internal environment. During exercise the contracting muscles generate force or power and heat. So physical exercise is in fact a form of mechanical energy. This generated energy will deplete the energy stocks within the body. During exercise, metabolites and heat are generated, which affect the steady state of the internal environment. Depending on the form of exercise, sooner or later sensations of fatigue and exhaustion will occur. The physiological role of these sensations is protection of the exercising subject from the deleterious effects of exercise. Because of these sensations the subject will adapt his or her exercise strategy. The relationship between physical exercise and fatigue has been the scope of interest of many researchers for more than a century and is very complex.
The exercise intensity, exercise endurance time and type of exercise are all variables that cause different effects within the body systems, which in turn create different types of sensation within the subject’s mind during the exercise.
Physical exercise affects the biochemical equilibrium within the exercising muscle cells. Among others, inorganic phosphate, protons, lactate and free Mg2+ accumulate within these cells. They directly affect the mechanical machinery of the muscle cell. Furthermore, they negatively affect the different muscle cell organelles that are involved in the transmission of neuronal signals.
The muscle metabolites produced and the generated heat of muscle contraction are released into the internal environment, putting stress on its steady state. The tremendous increase in muscle metabolism compared with rest conditions induces an immense increase in muscle blood supply, causing an increase in the blood circulatory system and gas exchange. Nutrients have to be supplied to the exercising muscle, emptying the energy stocks elsewhere in body. Furthermore, the contracting muscle fibres release cytokines, which in their turn create many effects in other organs, including the brain. All these different mechanisms sooner or later create sensations of fatigue and exhaustion in the mind of the exercising subject. The final effect is a reduction or complete cessation of the exercise.
Many diseases speed up the depletion of the energy stocks within the body. So diseases amplify the effect of energy stock depletion that accompanies exercise. In addition, many diseases produce a change of mind-set before exercise. These changes of mind-set can create sensations of fatigue and exercise-avoiding behaviour at the onset of an exercise. One might consider these sensations during disease as a feed-forward mechanism to protect the subject from an excessive depletion of their energy stocks, to enhance the survival of the individual during disease.
Literature
1.
Gandevia SC. Spinal and supraspinal factors in human muscle fatigue. Physiol Rev 2001; 81: 1725–89PubMed
2.
3.
Human muscle fatigue: physiological mechanism. Ciba Foundation Symposium no. 82. London: Pitman Medical 1981
4.
Borg G. Psychophysical scaling with applications in physical work and the perception of exertion. Scand J Work Environ Health 1990; 16 Suppl. 1: 55–8PubMedCrossRef
5.
Lehninger AL. Contraction and motion (chapter 11). In: Lehninger AL, editor. Bioenergetics: the molecular basis of biological energy transformations. 2nd ed. New York: WA Benjamin Inc., 1971: 211–24 (ISBN 0-8053-6103-0)
6.
Murray RK. Muscle (chapter 58). In: Murray RK, Granner DK, Mayes PA, et al., editors. Harper’s Biochemistry. 23rd ed. Norwalk (VA): Appleton & Lange, 1993: 647–64 (ISBN 0-8385-3658-1)
7.
Chance B, Eleff S, Leigh Jr JS, et al. Mitochondrial regulation of phosphocreatine/inorganic phosphate ratios in exercising human muscle: a gated 31P NMR study. Proc Natl Acad Sci USA 1981; 78: 6714–8PubMedCrossRef
8.
Minotti JR, Johnson EC, Hudson TL, et al. Forearm metabolic asymmetry detected by 31P-NMR during submaximal exercise. J Appl Physiol 1989; 67: 324–9PubMed
9.
Molé PA, Coulson RL, Caton JR, et al. In vivo 31P-NMR in human muscle: transient patterns with exercise. J Appl Physiol 1985; 59: 101–4PubMed
10.
Sapega AA, Sokolow DP, Graham TJ, et al. Phosphorus nuclear magnetic resonance: a non-invasive technique for the study of muscle bioenergetics during exercise. Med Sci Sports Exerc 1987; 19: 410–20PubMed
11.
Cooke R. Actomyosin interaction in striated muscle. Physiol Rev 1997; 77: 671–9PubMed
12.
Lionne C, Brune M, Webb MR, et al. Time resolved measurements show that phosphate release is the rate limiting step on myofibrillar ATPases. FEBS Lett 1995; 364: 59–62PubMedCrossRef
13.
Lamb GD, Stephenson DG. Effects of intracellular pH and [Mg2+] on excitation-contraction coupling in skeletal muscle fibres of the rat. J Physiol 1994; 478: 331–9PubMed
14.
Potma EJ, van Graas IA, Stienen GJM. Effects of pH on myofibrillar ATPase activity in fast and slow skeletal muscle fibres of the rabbit. Biophys J 1994; 67: 2404–10PubMedCrossRef
15.
Karatzaferi C, Myburgh KH, Chinn MK, et al. Effect of an ADP analog on isometric force and ATPase activity of active muscle fibers. Am J Physiol 2003; 284: C816–25
16.
Cooke R, Franks K, Luciani GB, et al. The inhibition of rabbit skeletal muscle contraction by hydrogen ions and phosphate. J Physiol 1988; 395: 77–97PubMed
17.
Myburgh KH. Can any metabolites partially alleviate fatigue manifestations at the cross-bridge? Med Sci Sports Exerc 2004; 36: 20–7PubMedCrossRef
18.
Westerblad H, Bruton JD, Lännergren J. The effect of intracellular pH on contractile function of intact, single fibres of mouse muscle declines with increasing temperature. J Physiol 1997; 500: 193–204PubMed
19.
Cooke R, Pate E. The effects of ADP and phosphate on the contraction of muscle fibers. Biophys J 1985; 48: 789–98PubMedCrossRef
20.
Metzger JM. Effects of phosphate and ADP on shortening velocity during maximal and submaximal calcium activation of the thin filament in skeletal muscle fibers. Biophys J 1996; 70: 409–17PubMedCrossRef
21.
Millar NC, Homsher E. Kinetics of force generation and phosphate release in skinned rabbit soleus muscle fibers. Am J Physiol 1992; 262: C1239–45
22.
Stienen GJ, Roosemalen MC, Wilson MG, et al. Depression of force by phosphate in skinned skeletal muscle fibers of the frog. Am J Physiol 1990; 259: C349–57
23.
Potma EJ, van Graas IA, Stienen GJM. Influence of inorganic phosphate and pH on ATP utilization in fastand slow skeletal muscle fibres. Biophys J 1995; 67: 2580–9CrossRef
24.
Potma EJ, Stienen GJM. Increase in ATP consumption during shortening in skinned fibers from rabbit psoas muscle: effects of inorganic phosphate. J Physiol 1996; 496: 1–12PubMed
25.
Coyle EF, Coggan AR, Hemmert MK, et al. Muscle glycogen utilization during prolonged strenuous exercise when fed carbohydrate. J Appl Physiol 1986; 61: 165–72PubMed
26.
McArdle WD, Katch FI, Katch VL, editors. Exercise physiology: energy III and human performance. 4th ed. Baltimore (MD): Williams & Wilkins, 1996 (ISBN 0-683-05731-6)
27.
Powers SK, Howley ET, editors. Exercise physiology: theory and application to fitness and performance. 2nd ed. Madison (WI) and Dubuque (IA): WCB Brown & Benchmark Publishers, 1994 (ISBN 0-697-12657-9)
28.
Hayashi T, Wojtaszewski JF, Goodyear LJ. Exercise regulation of glucose transport in skeletal muscle. Am J Physiol 1997; 273: E1039–51
29.
Frandsen U, Lopez-Figueroa M, Hellsten Y. Localization of nitric oxide synthase in human skeletal muscle. Biochem Biophys Res Commun 1996; 227: 88–93PubMedCrossRef
30.
Bradley SJ, Kingwell BA, McConell GK. Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans. Diabetes 1999; 48: 1815–21PubMedCrossRef
31.
Mayes PA. Integration of metabolism and the provision of tissue fuels (chapter 29). In: Murray RK, Granner DK, Mayes PA, Rodwell PA, editors. Harper’s Biochemistry. 23rd ed. Norwalk (VA): Appleton & Lange, 1993: 279–92 (ISBN 0-8385-3658-1)
32.
33.
Balog EM, Thomson LV, Fitts RH. Role of sarcolemma action potentials and excitability in muscle fatigue. J Appl Physiol 1994; 76: 2157–62PubMedCrossRef
34.
Lännergren J, Westerblad H. Action potential fatigue in single skeletal muscle fibres of Xenopus. Acta Physiol Scand 1987; 129: 311–8PubMedCrossRef
35.
Metzger JM, Fitts RH. Fatigue from high- and low-frequency muscle stimulation: role of sarcolemma action potentials. Exp Neurol 1986; 93: 320–33PubMedCrossRef
36.
Juel C. Potassium and sodium shifts during in vitro isometric muscle contraction, and the time course of the ion-gradient recovery. Eur J Appl Physiol (Pflügers Arch) 1986; 406: 458–63CrossRef
37.
Juel C. Muscle action potential propagation velocity changes during activity. Muscle Nerve 1988; 11: 714–9PubMedCrossRef
38.
Lindström L, Kadefors R, Petersén I. An electromyographic index for localized muscle fatigue. J Appl Physiol 1977; 43: 750–4PubMed
39.
de Luca CJ. Myoelectric manifestations of localized muscular fatigue in humans. Crit Rev Biomed Eng 1984; 11: 251–79PubMed
40.
Ament W, Bonga GJ, Hof AL, et al. Electromyogram median power frequency in exhausting exercise. J Electromyogr Kinesiol 1993; 3: 214–20PubMedCrossRef
41.
Ament W, Bonga GJ, Hof AL, et al. Electromyogram median power frequency in dynamic exercise at medium exercise intensities. Eur J Appl Physiol (Pflügers Arch) 1996; 74: 180–6
42.
Jansen R, Ament W, Verkerke GJ, et al. Median power frequency of the surface electromyogram and blood lactate concentration in incremental cycle ergometry. Eur J Appl Physiol (Pflügers Arch) 1997; 75: 102–8
43.
Buchthal F, Madsen A. Synchronous activity in normal and atrophic muscle. Electroencephalogr Clin Neurophysiol 1950; 2: 425–44PubMedCrossRef
44.
Datta AK, Stephens JA. Synchronization of motor units activity during voluntary contraction in man. J Physiol 1990; 442: 397–419
45.
Allen DG, Lamb GD, Westerblad H. Skeletal muscle fatigue: cellular mechanisms. Physiol Rev 2008; 88: 287–332PubMedCrossRef
46.
Bigland-Ritchie B, Rice CL, Garland SJ, et al. Task-dependent factors in fatigue of human voluntary contractions (chapter 27). In: Gandevia SC, Enoka RM, McComas AJ, et al., editors. Fatigue: neural and muscular mechanisms–advances in medicine and biology (volume 384). New York & London: Plenum Press, 1995: 361–80 (ISBN 0-306-45139-5)
47.
Garland SJ, Enoka RM, Serrano LP, et al. Behavior of motor units in human biceps brachii during a submaximal fatiguing contraction. J Appl Physiol 1994; 76: 2411–19PubMed
48.
49.
Lännergren J, Westerblad H. Force and membrane potential during and after fatiguing, continuous high-frequency stimulation of single Xenopus muscle fibres. Acta Physiol Scand 1986; 128: 359–68PubMedCrossRef
50.
Bergström M, Hultman E. Relaxation and force during fatigue and recovery of the human quadriceps muscle: relations to metabolite changes. Eur J Appl Physiol(Pflügers Arch) 1991; 418: 153–60
51.
52.
53.
Wolfe GI, Baker NS, Haller RG, et al. McArdle’s disease presenting with asymmetric, late-onset arm weakness. Muscle Nerve 2000; 23: 641–5PubMedCrossRef
54.
Cady EB, Elshove H, Jones DA, et al. Themetabolic causes of slow relaxation in fatigued human skeletal muscle. J Physiol 1989; 418: 327–37PubMed
55.
Lamb GD, Stephenson DG, Stienen GJM. Effects of osmolality and ionic strength on the mechanism of Ca2+ release in skinned skeletal muscle fibres of the toad. J Physiol 1993; 464: 629–48PubMed
56.
Meissner G. Ryanodine receptor/Ca2+ release channels and their regulation by endogenous effectors. Annu Rev Physiol 1994; 56: 485–508PubMedCrossRef
57.
Westerblad H, Allen DG. Myoplasmic free Mg2+ concentration during repetitive stimulation of single fibres from mouse skeletal muscle. J Physiol 1992; 453: 413–34PubMed
58.
Allen DG, Westerblad H. Role of phosphate and calcium stores in muscle fatigue. J Physiol 2001; 536: 657–65PubMedCrossRef
59.
Newton DW, Driscoll DF. Calcium and phosphate compatibility: revisited again. Am J Health Syst Pharm 2008; 65: 73–80PubMedCrossRef
60.
Marx SO, Reiken S, Hismatsu Y, et al. Phosphorylation-dependent regulation of ryanodine receptors: a novel role for leucine/isoleucine zippers. J Cell Biol 2001; 153: 699–708PubMedCrossRef
61.
Dulhunty AF, Laver D, Curtis SM, et al. Characteristics of irreversible ATP activation suggest that native skeletal ryanodine receptors can be phosphorylated via an endogenous CaMKII. Biophys J 2001; 81: 3240–52PubMedCrossRef
62.
Sjøgaard G, McComas AJ. Role of interstitial potassium (chapter 4). In: Gandevia SC, Enoka RM, McComas AJ, et al., editors. Fatigue: neural and muscular mechanisms–advances in medicine and biology (volume 384). New York & London: Plenum Press, 1995: 69–80 (ISBN 0-306-45139-5)
63.
Sjøgaard G, Adams RP, Saltin B. Water and ion shifts in skeletal muscle of humans with intense dynamic knee extension. Am J Physiol 1985; 248: R190–6
64.
Busse MW, Maassen N. Effect of consecutive exercise bouts on plasma potassium concentration during exercise and recovery. Med Sci Sports Exerc 1989; 21: 489–93PubMed
65.
Medbo JI, Sejersted OM. Plasma K+ changes during intense exercise in endurance-trained and sprint-trained subjects. Acta Physiol Scand 1994; 151: 363–71PubMedCrossRef
66.
Kearney MT, Cotton JM, Richardson PJ, et al. Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management. Postgrad Med J 2001; 77: 4–10PubMedCrossRef
67.
Woodruff JF. Viral myocarditis: a review. Am J Pathol 1980; 101: 425–84PubMed
68.
Gibson TC, Arnold J, Craige E, et al. Electrocardiographic studies in Asian influenza. Am Heart J 1959; 57: 661–8PubMedCrossRef
69.
del Castillo J, Katz B. The effect of magnesium on the activity of motor nerve endings. J Physiol 1954; 124: 553–9
70.
Smith DO. Acetylcholine storage, release and leakage at the neuromuscular junction of mature and aged rats. J Physiol 1984; 347: 161–76PubMed
71.
Feltz A, Trautmann A. Desensitization at the frog neuromuscular junction: a biphasic process. J Physiol 1982; 332: 257–72
72.
Bigland-Ritchie B, Kukulka CG, Lippold OCJ, et al. The absence of neuromuscular transmission failure in sustained maximal voluntary contractions. J Physiol 1982; 330: 165–78
73.
Ghez C. Muscles: effectors of the motor systems (chapter 36). In: Kandel ER, Schwartz JH, Jessell TM, editors. Principles of neural science (3rd ed). London: Prentice-Hall International, 1991: 548–63 (ISBN 0-8385-8068-8)
74.
Sandercock TG, Faulkner JA, Albers W, et al. Single motor unit and fiber action potentials during fatigue. J Appl Physiol 1985; 58: 1073–9PubMed
75.
Sieck GC, Fournier M. Changes in diaphragm motor unit EMG during fatigue. J Appl Physiol 1990; 68: 1917–26PubMed
76.
Burke RE. Motor units: anatomy, physiology, and functional organisation (chapter 10). In: Brookhart JM, Mountcastle VB, Brooks VB, editors. Handbook of physiology, section 1: the nervous system (volume II, part I), motor control. New York: Oxford University Press, 1981: 345–442 (ISBN 0-683-01105-7)
77.
Kernell D. Organized variability in the neuromuscular system: a survey of task-related adaptations. Arch Ital Biol 1992; 130: 19–66PubMed
78.
Pette D, Staron RS. Transitions of muscle fiber phenotypic profiles. Histochem Cell Biol 2001; 115: 359–72PubMed
79.
Coupland ME, Puchert E, Ranatunga KW. Temperature dependence of active tension in mammalian (rabbit psoas) muscle fibres: effect of inorganic phosphate. J Physiol 2001; 536: 879–91PubMedCrossRef
80.
Widrick JJ. Effect of P(i) on unloaded shortening velocity of slow and fast mammalian muscle fibers. Am J Physiol 2002; 282: C647–53
81.
Lionikas A, Li M, Larsson L. Human skeletal muscle myosin function at physiological and non-physiological temperatures. Acta Physiol 2006; 186: 151–8CrossRef
82.
Saltin B, Gagge AP, Stolwijk JAJ. Muscle temperature during submaximal exercise in man. J Appl Physiol 1968; 25: 679–88PubMed
83.
Ariano MA, Armstrong RB, Edgerton VR. Hindlimb muscle fiber populations of five mammals. J Histochem Cytochem 1973; 21: 51–5PubMedCrossRef
84.
Johnson MA, Polgar J, Weightman D, et al. Data on the distribution of fibre types in thirty-six human muscles: an autopsy study. J Neurol Sci 1973; 18: 111–29PubMedCrossRef
85.
Bigland-Ritchie B, Johansson R, Lippold OC, et al. Changes in single motor unit firing rates during sustained maximal voluntary contractions. J Physiol 1982; 328: 27P–8P
86.
Bigland-Ritchie B, Johansson R, Lippold OC, et al. Changes in motoneuron firing rates during sustained maximal voluntary contractions. J Physiol 1983; 340: 335–46PubMed
87.
Sacco P, Newberry R, McFadden L, et al. Depression of human electromyography activity by fatigue of a synergistic muscle. Muscle Nerve 1997; 20: 710–7PubMedCrossRef
88.
Fuglevand AJ, Keen DA. Re-evaluation of muscle wisdom in the human adductor pollicis using physiological rates of stimulation. J Physiol 2003; 549: 865–75PubMedCrossRef
89.
90.
Brooks GA. Anaerobic threshold: review of the concept and directions for future research. Med Sci Sports Exerc 1985; 17: 22–34PubMed
91.
Coyle EF, Coggan AR, Hopper MK, et al. Determinants of endurance in well-trained cyclists. J Appl Physiol 1988; 64: 2622–30PubMed
92.
Heck H, Mader A, Hess G, et al. Justification of the 4mmol/L lactate threshold. Int J Sports Med 1985; 6: 117–30PubMedCrossRef
93.
Goodman MN, Lowenstein JM. The purine nucleotide cycle. Studies of ammonia production by skeletal musclein situ and in perfused preparations. J Biol Chem 1977; 252: 5054–60
94.
Lowenstein JM. The purine nucleotide cycle revised. Int J Sports Med 1990; 11 Suppl. 2: S37–47CrossRef
95.
96.
Role LW, Kelly JP. The brain stem: cranial nerve nuclei and the monoaminergic systems (chapter 44). In: Kandel ER, Schwartz JH, Jessell TM, editors. Principles of neural science. 3rd ed. Glenview (IL): Prentice-Hall International, 1991: 683–99 (ISBN 0-8385-8068-8)
97.
Dodd J, Role LW. The autonomic nervous system (chapter 49). In: Kandel ER, Schwartz JH, Jessell TM, editors. Principles of neural science. 3rd ed. Glenview (IL): Prentice-Hall International, 1991: 761–75 (ISBN 0-8385-8068-8)
98.
Patla AE. Understanding the roles of vision in the control of human locomotion (review article). Gait Posture 1997; 5: 54–9CrossRef
99.
Garland SJ, Kaufman MP. Role of muscle afferents in the inhibition of motoneurons during fatigue (chapter 19). In: Gandevia SC, Enoka RM, McComas AJ, et al., editors. Fatigue: neural and muscular mechanisms–advances inmedicine and biology (volume 384). New York & London: Plenum Press, 1995: 271–80 (ISBN 0-306-45139-5)
100.
Hagbarth KE, Macefield VG. The fusimotor system: its role in fatigue (chapter 18). In: Gandevia SC, Enoka RM, McComas AJ, et al., editors. Fatigue: neural and muscular mechanisms–advances in medicine and biology (volume 384). New York & London: Plenum Press, 1995: 259–70 (ISBN 0-306-45139-5)
101.
Windhorst U, Boorman G. Overview: potential role of segmental motor circuitry in muscle fatigue (chapter 17). In: Gandevia SC, Enoka RM, McComas AJ, et al., editors. Fatigue: neural and muscular mechanisms–advances inmedicine and biology (volume 384). New York & London: Plenum Press, 1995: 241–58 (ISBN 0-306-45139-5)
102.
Bigland-Ritchie BR, Dawson NJ, Johansson RS, et al. Reflex origin for the slowing of motoneurone firing ratesin fatigue of human voluntary contractions. J Physiol 1986; 379: 451–9PubMed
103.
Martin PG, Smith JL, Butler JE, et al. Fatigue-sensitive afferents inhibit extensor but not flexor motoneurons in humans. J Neurosci 2006; 26: 4796–802PubMedCrossRef
104.
Martin PG, Weerakkody N, Gandevia SC, et al. Group III and IV muscle afferents differentially affect the motorcortex and motoneurons in humans: afferents inhibit extensor but not flexor motoneurons in humans. J Physiol 2008; 586: 1277–89PubMedCrossRef
105.
Nielsen J, Petersen N. Is presynaptic inhibition distributed to corticospinal fibres in man? J Physiol 1994; 477: 47–58PubMed
106.
Gandevia SC, Allen GM, Butler JE, et al. Supraspinal factors in human muscle fatigue: evidence for sub-optimal output from the motor cortex. J Physiol 1996; 490: 529–36PubMed
107.
Westerblad H, Lee JA, Lännergren J, et al. Cellular mechanisms of fatigue in skeletal muscle. Am J Physiol 1991; 261: C195–209
108.
Gandevia SC, Allen GM, McKenzie DK. Central fatigue: critical issues and practical implications (chapter 20). In: Gandevia SC, Enoka RM, McComas AJ, et al., editors. Fatigue: neural and muscular mechanisms–advances inmedicine and biology (volume 384). New York & London: Plenum Press, 1995: 281–94 (ISBN 0-306-45139-5)
109.
Merton PA. Voluntary strength and fatigue. J Physiol 1954; 123: 553–64PubMed
110.
Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985; 325 (8437): 1106–7CrossRef
111.
Taylor JL, Butler JE, Allen GM, et al. Changes in motor cortical excitability during human muscle fatigue. J Physiol 1996; 490: 519–28PubMed
112.
McCloskey DI. Corollary discharges: motor commands and perception. In: Brookhart JM, Mountcastle VB, Brooks VB, editors. Handbook of physiology, section 1: the nervous system (volume II, part II), Motor control. New York: Oxford University Press, 1981: 1415–48 (ISBN 0-683-01105-7)
113.
Jones LA. The senses of effort and force during fatiguing contractions (chapter 22). In: Gandevia SC, Enoka RM, McComas AJ, et al., editors. Fatigue: neural and muscular mechanisms–advances in medicine and biology (volume 384). New York & London: Plenum Press, 1995: 305–13 (ISBN 0-306-45139-5)
114.
Brengelmann GL. Body temperature regulation (chapter 80). In: Patton HD, Fuchs AF, Hille B, et al., editors. Textbook of physiology, volume II. 21st ed. Philadelphia (PA): W.B. Saunders Company, 1989: 1584–96 (ISBN 0-7216-2524-X)
115.
Johnson JM, Brengelmann GL, Hales JRS, et al. Regulation of the cutaneous circulation. Fed Proc 1986; 45: 2841–50PubMed
116.
Nagashima K, Nakai S, Tanaka M, et al. Neuronal circuits involved in thermo regulation. Auton Neurosci 2000; 85: 18–25PubMedCrossRef
117.
Gonzalez-Alonso J, Teller C, Andersen SL, et al. Influence of body temperature on the development of fatigue during prolonged exercise in the heat. J Appl Physiol 1999; 86: 1032–9PubMed
118.
Nielsen B, Hyldig T, Bidstrup F, et al. Brain activity and fatigue during prolonged exercise in the heat. Eur J Physiol (Pflügers Arch) 2001; 442: 41–8CrossRef
119.
120.
Todd G, Butler JE, Taylor JL, et al. Hyperthermia: a failure of the motor cortex and the muscle. J Physiol 2005; 563: 621–31PubMedCrossRef
121.
Reza MF, Ikoma K, Chuma T, et al. Mechanomyographic response to transcranial magnetic stimulation from biceps brachii and during transcutaneous electrical nerve stimulation of extensor carpi radialis. J Neurosci Methods 2005; 49: 164–71CrossRef
122.
Lacerda AC, Marubayashi U, Coimbra CC. Nitric oxide pathway is an important modulator of heat loss in rats during exercise. Brain Res Bull 2005; 67: 110–6PubMedCrossRef
123.
Lacerda AC, Marubayashi U, Balthazar CH, et al. Evidence that brain nitric oxide inhibition increases metabolic cost of exercise, reducing running performance in rats. Neurosci Lett 2006; 393: 260–3PubMedCrossRef
124.
Cheung SS, Sleivert GG. Multiple triggers for hyperthermic fatigue and exhaustion. Exerc Sport Sci Rev 2004; 32: 100–6PubMedCrossRef
125.
Newsholme EA, Blomstrand E. Tryptophan 5-hydroxytryptamine and a possible explanation for central fatigue (chapter 23). In: Gandevia SC, Enoka RM, McComas AJ, et al., editors. Fatigue: neural and muscular mechanisms–advances in medicine and biology (volume 384). New York & London: Plenum Press, 1995: 315–20 (ISBN 0-306-45139-5)
126.
Blomstrand E, Moller K, Secher NH, et al. Effect of carbohydrate ingestion on brain exchange of amino acids during sustained exercise in human subjects. Acta Physiol Scand 2005; 185: 203–9PubMedCrossRef
127.
Cheuvront SN, Carter 3rd R, Kolka MA, et al. Branched-chain amino acid supplementation and human performance when hypohydrated in the heat. J Appl Physiol 2004; 97: 1275–82PubMedCrossRef
128.
Ostrowski K, Hermann C, Bangash A, et al. A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol 1998; 513: 889–94PubMedCrossRef
129.
Ostrowski K, Rohde T, Zacho M, et al. Evidence that interleukin-6 is produced by skeletal muscle during prolonged exercise. J Physiol 1998; 503: 949–53CrossRef
130.
Ostrowski K, Schjerling P, Pedersen BK. Physical activity and plasma interleukin-6 in humans: effect of intensity of exercise. Eur J Appl Phsyiol (Pflügers Arch) 2000; 83: 512–5
131.
Steensberg A, van Hall G, Osada T, et al. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 2000; 529: 237–42PubMedCrossRef
132.
Febbraio MA, Steensberg A, Keller C, et al. Glucose ingestion attenuates interleukin-6 release from contracting muscle in humans. J Physiol 2003; 549: 607–12PubMedCrossRef
133.
Helge JW, Stallknecht B, Pedersen BK, et al. The effect of graded exercise on IL-6 release and glucose uptake in human skeletal muscle. J Physiol 2003; 546: 299–305PubMedCrossRef
134.
Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration and adaptation. Physiol Rev 2000; 80: 1055–81PubMed
135.
Keller C, Steensberg A, Hansen AK, et al. Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle. J Appl Physiol 2005; 99: 2075–9PubMedCrossRef
136.
Clarkson PM, Hubal MJ. Exercise-induced muscle damage in humans. Am J Phys Med Rehabil 2002; 81Suppl. 11: S52–69CrossRef
137.
Petersen AMW, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98: 1154–62PubMedCrossRef
138.
139.
Ostrowski K, Rohde T, Asp S, et al. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 1999; 515: 287–91PubMedCrossRef
140.
Tomiya A, Aizawa T, Nagatomi R, et al. Myofibers express IL-6 after eccentric exercise. Am J Sports Med 2004; 32: 503–8PubMedCrossRef
141.
Nieman DC, Davis JM, Henson DU, et al. Muscle cytokine mRNA changes after 2.5 h of cycling: influence of carbohydrate. Med Sci Sports Exerc 2005; 37: 1283–90PubMedCrossRef
142.
Nieman DC, Davis JM, Walberg-Rankin J, et al. Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after 3-h run. J Appl Physiol 2003; 94: 1917–25PubMed
143.
Kapsimalis F, Richardson G, Opp MR, et al. Cytokines and normal sleep. Curr Opin Pulm Med 2005; 11: 481–4PubMedCrossRef
144.
Blatteis CM, Li S, Li Z, et al. Cytokines, PGE2 and endotoxic fever a re-assessment (review). Prostaglandins Other Lipid Mediat 2005; 76: 1–8PubMedCrossRef
145.
Robson-Ansley PJ, de Milander L, Collins M, et al. Acute interleukin-6 administration impairs athletic performance in healthy, trained male runners. Can J Appl Physiol 2004; 29: 411–8PubMedCrossRef
146.
Dantzer R. Cytokine-induced sickness behaviour: a neuroi-mmune response to activation of innate immunity. Eur J Pharmacol 2004; 500: 399–411PubMedCrossRef
147.
Vollmer-Conna U, Fazou C, Cameron B, et al. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med 2004; 34: 1289–97PubMedCrossRef
148.
Herholz K, Buskies W, Rist M, et al. Regional cerebral blood flow in man at rest and during exercise. J Neurol 1987; 234: 9–13PubMedCrossRef
149.
Ide K, Horn A, Secher NH. Cerebral metabolic response to submaximal exercise. J Appl Physiol 1999; 87: 1604–8PubMed
150.
Dalsgaard MK, Ide K, Cai Y, et al. The intent to exercise influences the cerebral O2/carbohydrate uptake ratio in humans. J Physiol 2002; 540: 681–9PubMedCrossRef
151.
Noakes TD. Maximal oxygen uptake: “classical” versus “contemporary” viewpoints: a rebuttal. Med Sci Sports Med 1998; 30: 1381–98
152.
Noakes TD. The Central Governor Model of exercise regulation applied to the marathon. Sports Med 2007; 37: 374–7PubMedCrossRef
153.
Noakes TD, St Clair Gibson A. From catastrophe to complexity: a novel model of integrative central neural regulation of effort and fatigue during exercise in humans: summary and conclusions. Br J Sports Med 2004; 38: 511–4PubMedCrossRef
154.
Nybo L, Nielsen B. Middle cerebral artery blood velocity is reduced with hyperthermia during prolonged exercise in humans. J Physiol 2001; 534: 279–86PubMedCrossRef
155.
Madsen PL, Sperling BK, Warming T, et al. Middle cerebral artery blood velocity and cerebral blood flow and O2 uptake during dynamic exercise. J Appl Physiol 1993; 74: 245–50PubMed
156.
Hasselbalch SG, Madsen PL, Hageman LP, et al. Changes in cerebral blood flow and carbohydrate metabolism during hyperketonemia. Am J Physiol 1996; 270: E746–51
157.
Ide K, Schmalbruch IK, Quistorff B, et al. Lactate, glucose and O2 uptake in human brain during recovery from maximal exercise. J Physiol 2000; 522: 159–64PubMedCrossRef
158.
Kemppainen J, Aalto S, Fujimoto T, et al. High intensity exercise decreases global brain glucose uptake in humans. J Physiol 2005; 568: 323–32PubMedCrossRef
159.
Kernell D. Neuromuscular frequency-coding and fatigue (chapter 9). In: Gandevia SC, Enoka RM, McComas AJ, et al., editors. Fatigue: neural and muscular mechanisms–advances in medicine and biology (volume 384). New York & London: Plenum Press, 1995: 135–45 (ISBN 0-306-45139-5)
160.
Lévesque M, Charara A, Gagnon S, et al. Corticostriatal projections from layer V cells in rat are collaterals of long-range corticofugal axons. Brain Res 1996; 709: 311–5PubMedCrossRef
161.
Parent M, Parent A. Single-axon tracing study of corticostriatal projections arising from primary motor cortexin primates. J Comp Neurol 2006; 496: 202–13PubMedCrossRef
162.
Reiner A, Jiao Y, del Mar N, et al. Differential morphology of pyramidal tract-type and intratelencephalically projecting-type corticostriatal neurons and their intrastriatal terminals in rats. J Comp Neurol 2003; 457: 420–40PubMedCrossRef
163.
St Clair Gibson A, Baden DA, Lambert MI, et al. The conscious perception of the sensation of fatigue. Sports Med 2003; 33: 167–76PubMedCrossRef
164.
Laureys S, Owen AM, Schiff ND. Brain function in coma, vegetative state, and related disorders. Lancet Neurol 2004; 3: 537–46PubMedCrossRef
165.
Cavanna AE, Trimble MR. The precuneus: a review of its functional anatomy and behavioural correlates. Brain 2006; 129: 564–83PubMedCrossRef
166.
Borg GAV. Physical performance and perceived exertion. Dissertation Lund University (Sweden), 1962
167.
Borg E, Borg G. A comparison of AME and CR 100 for scaling perceived exertion. Acta Psychol (Amst) 2002; 190: 157–75CrossRef
168.
Allman BL, Rice CL. Perceived exertion is elevated in old age during an isometric fatigue task. Eur J Appl Physiol 2003; 89: 191–7PubMedCrossRef
169.
Hummel A, Läubli T, Pozzo M, et al. Relationship between perceived exertion and mean power frequency of the EMG signal from the upper trapezius muscle during isometric shoulder elevation. Eur J Appl Physiol 2005; 95: 321–6PubMedCrossRef
170.
Hampson DB, St Clair Gibson A, Lambert MI, et al. The influence of sensory cues on the perception of exertion during exercise and central regulation of exercise performance. Sports Med 2001; 31: 935–52PubMedCrossRef
171.
Davies CT, Sargeant AJ. The effects of atropine and practolol on the perception of exertion during treadmill exercise. Ergonomics 1979; 22: 1141–6PubMedCrossRef
172.
Ekblom B, Goldbarg AN. The influence of physical training and other factors on the subjective rating of perceived exertion. Acta Physiol Scand 1971; 83: 399–406PubMedCrossRef
173.
Eston R, Connolly D. The use of ratings of perceived exertion for exercise prescription in patients receiving β-blocker therapy. Sports Med 1996; 21: 176–90PubMedCrossRef
174.
Tesch PA, Kaiser P. Effects of β-adrenergic blockade on O2 uptake during submaximal and maximal exercise. J Appl Physiol 1983; 54: 901–5PubMed
175.
Pandolf KB, Noble BJ. The effect of pedaling speed and resistance changes on perceived exertion for equivalent power outputs on the bicycle ergometer. Med Sci Sports 1973; 5: 132–6PubMed
176.
Kohler G, Boutellier U. The generalized force-velocity relationship explains why the preferred pedalling rate of cyclists exceeds the most efficient one. Eur J Appl Physiol 2005; 94: 188–95PubMedCrossRef
177.
Baron R. Aerobic and anaerobic power characteristics of off-road cyclists. Med Sci Sports Exerc 2001; 33: 1387–93PubMedCrossRef
178.
Ulmer H-V. Concept of extracellular regulation ofmuscular metabolic rate during heavy exercise in humans by psychophysiological feedback. Experientia 1996; 52: 416–20PubMedCrossRef
179.
Eston R, Faulkner J, St Clair Gibson A, et al. The effect of antecedent fatiguing activity on the relationship between perceived exertion and physiological activity during a constant load exercise task. Psychophysiology 2007; 44: 779–86PubMedCrossRef
180.
Eston RG, Lamb KL, Parfitt G. The validity of predicting maximal oxygen uptake from a perceptually-regulated graded exercise test. Eur J Appl Physiol 2005; 94: 221–7PubMedCrossRef
181.
Weir JP, Beck TW, Cramer JT, et al. Is fatigue all in your head? A critical review of the central governor model. Br J Sports Med 2006; 40: 573–86
182.
Jones DA, Round JM. Training for power (chapter 6) In: Jones DA, Round JM, editors. Skeletal muscle in health and disease. Manchester: Manchester University Press, 1990 (ISBN 0-719031648)
183.
Ferreira LF, McDonough P, Behnke BJ, et al. Blood flow and O2 extraction as a function of O2 uptake in muscles composed of different fiber types. Respir Physiol Neurobiol 2006; 153: 237–49PubMedCrossRef
184.
Marsh RL, Ellerby DJ. Partitioning locomotor energy use among and within muscles: muscle blood flow as a measure of muscle oxygen consumption. J Exp Biol 2006; 209: 2385–94PubMedCrossRef
185.
Butler AB, Hodos W. Comparative vertebrate neuroanatomy. Butler AB, Hodos W, editors. 2nd ed. Hoboken (NY): John Wiley & Sons Inc., 2005: 139–55, 221-39
186.
Lacalli TC. New perspectives on the evolution of protochordate sensory and locomotory systems, and the origin of brains and head. Phil Trans R Soc 2001; 356: 1565–73CrossRef
187.
Bone Q. Evolutionary patterns of axial muscle systems in some invertebrates and fish. Am Zoologist 1989; 29: 5–18
188.
Wicht H, Lacalli TC. The nervous system of amphioxus: structure, development, and evolutionary significance. Can J Zool 2005; 83: 122–50CrossRef
189.
Rohmert W. Ermittlung von Erholungspause für statische Arbeit des Menschen. Int Z Angew Physiol 1960; 18: 123–64PubMed
190.
Barcroft H, Millen JLE. The blood flow through muscle during sustained contraction. J Physiol 1939; 97: 17–31PubMed
191.
Lind AR, Taylor SH, Humpreys PW, et al. The circulatory effects of sustained voluntary muscle contraction. Clin Sci 1964; 27: 229–44PubMed
192.
Kanemaki T, Kitade H, Kaibori M, et al. Interleukin 1β and interleukin 6, but not tumor necrosis factor α, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology 1998; 27: 1296–303PubMedCrossRef
193.
Febbraio MA, Hiscock N, Sacchetti M, et al. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes 2004; 53: 1643–8PubMedCrossRef
194.
Abdelmalki A, Merino D, Bonneau D, et al. Administration of a GABAB agonist baclofen before running to exhaustion in the rat: effects on performance and on some indicators of fatigue. Inter J Sports Med 1997; 18: 75–8CrossRef
195.
196.
Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. New Engl J Med 1999; 340: 448–54PubMedCrossRef
197.
Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood and cognition. Psychol Rev 1998; 105: 83–107PubMedCrossRef
198.
Kent S, Bluthe RM, Dantzer R, et al. Different receptor mechanisms mediate pyrogenic and behavioral effects of interleukin-1. Proc Natl Acad Sci USA 1992; 89: 9117–20PubMedCrossRef
199.
Wang J, Ando T, Dunn AJ. Effect of homologous interleukin-1, interleukin-6 and tumor necrosis factor-alpha on the core body temperature of mice. Neuro-immunomodulation 1997; 4: 230–6
200.
Blatteis CM. Endotoxic fever: new concepts of its regulation suggest new approaches to its management. Pharmacol Ther 2006; 111: 194–223PubMedCrossRef
201.
Lewis MI, Monn SA, Sieck GC. Effect of corticosteroids on diaphragm fatigue, SDH activity, and muscle fiber size. J Appl Physiol 1992; 72: 293–301PubMed
202.
Topp KS, Painter PL, Walcott S, et al. Alterations in skeletal muscle structure are minimized with steroid withdrawal after renal transplantation. Transplantation 2003; 76: 667–73PubMedCrossRef
203.
Tarnopolsky MA, MacDougall JD, Atkinson SA. Influence of protein intake and training status on nitrogen balance and lean body mass. J Appl Physiol 1988; 64: 187–93PubMed
204.
Mishra DK, Fridén J, Schmitz MC, et al. Anti-inflammatory medication after muscle injury: a treatment resulting in short-term improvement but subsequent loss of muscle function. J Bone Joint Surg Am 1995; 77: 1510–9PubMed
205.
Discussion between Swaak (physician) and Mishra (et al.). J Bone Joint Surg (Am) 1997; 79: 1270–1
206.
Belardinelli R, Barstow T, Nguyen P, et al. Skeletal muscle oxygenation and oxygen uptake kinetics following constant work rate exercise in chronic congestive heart failure. Am J Cardiol 1997; 80: 1319–25PubMedCrossRef
207.
Lele SS, Macfarlane D, Morrison S, et al. Determinants of exercise capacity in patients with coronary artery disease and mild to moderate systolic dysfunction. Eur Heart J 1996; 17: 204–12PubMedCrossRef
208.
Wasserman K. Diagnosing cardiovascular and lung pathophysiology from exercise gas exchange. Chest 1997; 112: 1091–101PubMedCrossRef
209.
Rus HG, Vlaicu R, Niculescu F. Interleukin-6 and interleukin- 8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996; 127: 263–71PubMedCrossRef
210.
Rus HG, Niculescu F, Vlaicu R. Tumor necrosis factoralpha in human arterial wall with atherosclerosis. Atherosclerosis 1991; 89: 247–54PubMedCrossRef
211.
Ridker PM, Rifai N, Stampfer MJ, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767–72PubMedCrossRef
212.
Johnson JM. Circulation to skeletal muscle. In: Patton HD, Fuchs AF, Hille B, et al., editors. Textbook of physiology, vol. 2. 21st ed. Philadelphia (PA): W.B. Saunders Company, 1989: 87–889 (ISBN 0-7216-2524-X)
213.
Pijls NHJ, deBruyne B. The coronary circulation (chapter 2). In: Coronary pressure. 2nd ed. Boston (MA): Kluwer Academic Publishers, 2000 (ISBN 0-792361709)
214.
Shankaran V, Ikeda H, Bruce AT, et al. IFNγ and lymphocytes prevent primary tumour development and shape tumor immunogenicity. Nature 2001; 410: 1107–11PubMedCrossRef
215.
Smyth MJ, Dunn GP, Schreiber RD. Cancer immuno-surveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol 2006; 90: 1–50PubMedCrossRef
216.
Bui JD, Schreiber RD. Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes? Curr Opin Immunol 2007; 19: 203–8PubMedCrossRef
217.
Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol 2004; 22: 329–60PubMedCrossRef
218.
Luo JL, Kamata H, Karin M. IKK/ NK-κB signaling: balancing life and death–a new approach to cancer therapy. J Clin Invest 2005; 115: 2625–32PubMedCrossRef
219.
Luo JL, Maeda S, Hus LC, et al. Inhibition of NK-κB in cancer cells converts inflammation-induced tumor growth mediated by TNFα to TRIAL-mediated tumor regression. Cancer Cell 2004; 6: 297–305PubMedCrossRef
220.
Langowski JL, Zhang X, Wu L, et al. IL-23 promotes tumour incidence and growth. Nature 2006 Jul 27; 442 (7101): 461–5PubMedCrossRef
221.
Peake JM, Suzuki K, Hordern M, et al. Plasma cytokine changes in relation to exercise intensity and muscle damage. Eur J Appl Physiol 2005; 95: 514–21PubMedCrossRef
222.
Kim S, Keku TO, Martin C, et al. Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res 2008; 68: 323–8PubMedCrossRef
223.
Nery LE, Wasserman K, Andrews JD, et al. Ventilatory and gas exchange kinetics during exercise in chronic airways obstruction. J Appl Physiol 1982; 53: 1594–602PubMed
224.
Hlastala MP. Gas transport and exchange (chapter 53). In: Patton HD, Fuchs AF, Hille B, et al., editors. Textbook of physiology, volume II. 21st ed. Philadelphia (PA): W.B. Saunders Company, 1989: 1012–25 (ISBN 0-7216-2524-X)
225.
American Thoracic Society and European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Med 1999; 159: S1–40
226.
Hamaoka T, McCully KK, Quaresima V, et al. Near infrared spectroscopy/imaging for monitoring muscle oxygenation in healthy and diseased humans. J Biomedical Optics 2007; 12: 062105
227.
Bazelmans E, Bleijenberg G, Van Der Meer JW, et al. Is physical deconditioning a perpetuating factor in chronic fatigue syndrome? A controlled study on maximal exercise performance and relations with fatigue, impairment and physical activity. Psychol Med 2001; 31: 107–14
228.
Jammes Y, Steinberg JG, Mambrini O, et al. Chronic fatigue syndrome: assessment of increased oxidative stressand altered muscle excitability in response to incremental exercise. J Intern Med 2005; 257: 299–310PubMedCrossRef
229.
Sargent C, Scroop GC, Nemeth PM, et al. Maximal oxygen uptake and lactate metabolism are normal in chronic fatigue syndrome. Med Sci Sports Exerc 2002; 34: 51–6PubMed
230.
Wallman KE, Morton AR, Goodman C, et al. Physiological responses during a submaximal cycle test in chronic fatigue syndrome. Med Sci Sports Exerc 2004; 36: 1682–8PubMedCrossRef
231.
Cannon JG, Angel JB, Ball RW, et al. Acute phase responses and cytokine secretion in chronic fatigue syndrome. J Clin Immunol 1999; 19: 414–21PubMedCrossRef
232.
Peterson PK, Sirr SA, Grammith FC, et al. Effects of mild exercise on cytokines and cerebral blood flow in chronic fatigue syndrome. Clin Diagn Lab Immunol 1994; 1: 222–6PubMed
233.
Tomoda A, Joudoi T, Rabab E-M, et al. Cytokine production and modulation: comparison of patients with chronic fatigue syndrome and normal controls. Psychiatry Res 2005; 134: 101–4PubMedCrossRef
234.
Di Giorgio A, Hudson M, Jerjes W, et al. 24-Hour pituitary and adrenal hormone profiles in chronic fatigue syndrome. Psychosom Med 2005; 67: 433–40PubMedCrossRef
235.
de Lange FP, Kalkman JS, Bleijenberg G, et al. Gray matter volume reduction in the chronic fatigue syndrome. Neuroimage 2005; 26: 777–81PubMedCrossRef
236.
Schwarz L, Kindermann W. β-Endomorphin, catecholamines, and cortisol during exhaustive endurance exercise. Int J Sports Med 1989; 10: 324–8PubMedCrossRef
237.
Lehmann M, Foster C, Dickhuth H-H. Gastmann. Autonomic imbalance hypothesis and overtraining syndrome. Med Sci Sports Exerc 1998; 30: 1140–5
238.
Urhausen A, Gabriel HHW, Kindermann W. Impaired pituitary hormonal response to exhaustive exercise in overtrained endurance athletes. Med Sci Sports Exerc 1998; 30: 407–14PubMedCrossRef
239.
Smith LL. Cytokine hypothesis of overtraining: a physiological adaptation to excessive stress? Med Sci Sports Exerc 2000; 32: 317–31PubMedCrossRef
240.
Steinacker JM, Lormes W, Reissnecker S, et al. New aspects of the hormone and cytokine response to training. Eur J Appl Physiol 2004; 91: 382–91PubMedCrossRef
241.
Kuipers H, Keizer HA. Overtraining in elite athletes: review and directions for the future. Sports Med 1988; 6: 79–92PubMedCrossRef
Metadata
Title
Exercise and Fatigue
Authors
Wim Ament
Gijsbertus J. Verkerke
Publication date
01-05-2009
Publisher
Springer International Publishing
Published in
Sports Medicine / Issue 5/2009
Print ISSN: 0112-1642
Electronic ISSN: 1179-2035
DOI
https://doi.org/10.2165/00007256-200939050-00005

Other articles of this Issue 5/2009

Sports Medicine 5/2009 Go to the issue

Review Article

Characteristics of Physical Activity Guidelines and their Effect on Adherence

Review Article

Swimming Exercise

Leading Article

Platelet-Rich Therapies in the Treatment of Orthopaedic Sport Injuries

Current Opinion

Genetic Testing and Sports Medicine Ethics